Skip to content

Lautrec Wilson Radcliff, MD

NPI 1801801493ActiveIndividual· Internal Medicine, Nephrology· Opelika, AL

Internal Medicine, Nephrology (MD) in Opelika, Alabama, licensed in AL, with an NPI issued in July 2006. Part D covered 236 prescriptions written in 2024, 92% of them generic. Calliditas Therapeutics US Inc. was the largest of 2 companies reporting payments in 2025, $226.90 in all, mostly food and beverage.

Overview

NPI1801801493
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 30, 2006
Last updated in NPPESSep 13, 2011

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Nephrology Primary207RN0300X14179AL
Internal Medicine207R00000X14179AL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Nephrology (AL)

Part D prescriptions in 2024

Prescriptions (claims)236 · 504 30-day fills
Patients78
Total drug cost$57,162
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$226.90 · 2 payments from 2 companies
  • 2024$116.65 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Calliditas Therapeutics US Inc.$124.931
Novo Nordisk Inc$101.971

What the 2025 payments were for

  • Food and Beverage$226.90 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Nephrology providers in Opelika

All Internal Medicine, Nephrology providers in Alabama →